222 related articles for article (PubMed ID: 24324699)
1. The role of dynamic susceptibility contrast-enhanced perfusion MR imaging in differentiating between infectious and neoplastic focal brain lesions: results from a cohort of 100 consecutive patients.
Floriano VH; Torres US; Spotti AR; Ferraz-Filho JR; Tognola WA
PLoS One; 2013; 8(12):e81509. PubMed ID: 24324699
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI.
Haris M; Gupta RK; Singh A; Husain N; Husain M; Pandey CM; Srivastava C; Behari S; Rathore RK
Neuroradiology; 2008 Jun; 50(6):531-40. PubMed ID: 18379766
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
[TBL] [Abstract][Full Text] [Related]
4. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
Hu LS; Baxter LC; Smith KA; Feuerstein BG; Karis JP; Eschbacher JM; Coons SW; Nakaji P; Yeh RF; Debbins J; Heiserman JE
AJNR Am J Neuroradiol; 2009 Mar; 30(3):552-8. PubMed ID: 19056837
[TBL] [Abstract][Full Text] [Related]
5. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
[TBL] [Abstract][Full Text] [Related]
6. Arterial spin labeling perfusion: Prospective MR imaging in differentiating neoplastic from non-neoplastic intra-axial brain lesions.
Soni N; Srindharan K; Kumar S; Mishra P; Bathla G; Kalita J; Behari S
Neuroradiol J; 2018 Dec; 31(6):544-553. PubMed ID: 29890916
[TBL] [Abstract][Full Text] [Related]
7. Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma.
Ulmer S; Liess C; Kesari S; Otto N; Straube T; Jansen O
J Neurooncol; 2009 Jan; 91(2):213-20. PubMed ID: 18807224
[TBL] [Abstract][Full Text] [Related]
8. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
[TBL] [Abstract][Full Text] [Related]
9. Systematic assessment of multi-echo dynamic susceptibility contrast MRI using a digital reference object.
Stokes AM; Semmineh NB; Nespodzany A; Bell LC; Quarles CC
Magn Reson Med; 2020 Jan; 83(1):109-123. PubMed ID: 31400035
[TBL] [Abstract][Full Text] [Related]
10. Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?
Hourani R; Brant LJ; Rizk T; Weingart JD; Barker PB; Horská A
AJNR Am J Neuroradiol; 2008 Feb; 29(2):366-72. PubMed ID: 18055564
[TBL] [Abstract][Full Text] [Related]
11. Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma.
Wang F; Zhou X; Chen R; Kang J; Yang X; Lin J; Liu F; Cao D; Xing Z
Eur Radiol; 2023 Dec; 33(12):8800-8808. PubMed ID: 37439934
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR Imaging.
Cha J; Kim ST; Nam DH; Kong DS; Kim HJ; Kim YK; Kim HY; Park GM; Jeon P; Kim KH; Byun HS
Clin Neuroradiol; 2017 Sep; 27(3):329-334. PubMed ID: 26952018
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
14. Contrast-Enhanced Perfusion MR Imaging to Differentiate Between Recurrent/Residual Brain Neoplasms and Radiation Necrosis.
Metaweh NAK; Azab AO; El Basmy AAH; Mashhour KN; El Mahdy WM
Asian Pac J Cancer Prev; 2018 Apr; 19(4):941-948. PubMed ID: 29693348
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
16. Association of Relative Cerebral Blood Volume from Dynamic Susceptibility Contrast-Enhanced Perfusion MR with HER2 Status in Breast Cancer Brain Metastases.
Young JR; Ressler JA; Shiroishi MS; Mortimer JE; Schmolze D; Fitzgibbons M; Chen BT
Acad Radiol; 2023 Sep; 30(9):1816-1822. PubMed ID: 36549990
[TBL] [Abstract][Full Text] [Related]
17. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
[TBL] [Abstract][Full Text] [Related]
18. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
19. DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife.
Morabito R; Alafaci C; Pergolizzi S; Pontoriero A; Iati' G; Bonanno L; Gaeta M; Salpietro FM; Mormina E; Longo M; Granata F
Radiat Oncol; 2019 Apr; 14(1):65. PubMed ID: 30992043
[TBL] [Abstract][Full Text] [Related]
20. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.
Arvinda HR; Kesavadas C; Sarma PS; Thomas B; Radhakrishnan VV; Gupta AK; Kapilamoorthy TR; Nair S
J Neurooncol; 2009 Aug; 94(1):87-96. PubMed ID: 19229590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
